Drug Shortage Report for TARO-PRAVASTATIN

Last updated on 2022-11-24 History
Report ID 173651
Drug Identification Number 02284448
Brand name TARO-PRAVASTATIN
Common or Proper name PRAVASTATIN
Company Name SUN PHARMA CANADA INC
Market Status MARKETED
Active Ingredient(s) PRAVASTATIN SODIUM
Strength(s) 20MG
Dosage form(s) TABLET
Route of administration ORAL ORAL
Packaging size 100
ATC code C10AA
ATC description LIPID MODIFYING AGENTS, PLAIN
Reason for shortage Disruption of the manufacture of the drug.
Anticipated start date
Actual start date 2022-08-23
Estimated end date 2022-12-30
Actual end date
Shortage status Actual shortage
Updated date 2022-11-24
Company comments
Health Canada comments
Tier 3 Status No
Contact Address 126 EAST DRIVE
BRAMPTON, ONTARIO
CANADA L6T 1C1
Company contact information

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v6 2022-11-24 French Compare
v5 2022-11-24 English Compare
v4 2022-11-16 French Compare
v3 2022-11-16 English Compare
v2 2022-11-03 French Compare
v1 2022-11-03 English Compare

Showing 1 to 6 of 6